Tuberculin Purified Protein Derivative Immunotherapy in the Treatment of Viral Warts
Indian Journal of Drugs in Dermatology · 2016
DOI: 10.4103/2455-3972.184103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Drugs in Dermatology, 2016. Verfasst von Ajay Nimbalkar und 3 weiteren Autor:innen. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Introduction
Viral warts are caused by human papillomavirus. Although various treatment modalities are available, many of them result in the partial clearance of warts or recurrence. Immunotherapy has been tried in the recent times with variable success rates. We undertook a study to evaluate the safety and efficacy of immunotherapy using tuberculin purified protein derivative (PPD) for the treatment of viral warts. Materials and Methods: A total of 45 patients were included in the study. Each patient was injected with 10 TU of tuberculin PPD (0.1 ml) intralesionally in the largest wart at 2 weekly interval. A total of maximum six treatment sessions were conducted. Resolution of viral warts was considered as the clinical end point of the study. The clinical assessment was done by photographic measurements at baseline, before each treatment session, and 3 weeks after the completion of treatment.
Results
A total of 62.2% patients (28 out of 45) showed complete clearance at injected and distant warts, eight patients (17.8%) showed partial clearance, and nine patients (20%) showed no improvement. No significant side effects were observed except for localized hair loss around injected viral wart over the scalp.
Conclusion
Tuberculin PPD immunotherapy was found to be a safe and effective treatment modality for the treatment of viral warts.
Zitieren
APA
Nimbalkar, A., Pande, S., Sharma, R., & Borkar, M. (2016). Tuberculin Purified Protein Derivative Immunotherapy in the Treatment of Viral Warts. Indian Journal of Drugs in Dermatology. https://doi.org/10.4103/2455-3972.184103
Vancouver
Nimbalkar A, Pande S, Sharma R, Borkar M. Tuberculin Purified Protein Derivative Immunotherapy in the Treatment of Viral Warts. Indian Journal of Drugs in Dermatology. 2016. doi:10.4103/2455-3972.184103
BibTeX
@article{Nimbalkar2016,
author = {Nimbalkar, Ajay and Pande, Sushil and Sharma, Ramesh and Borkar, Milind},
title = {Tuberculin Purified Protein Derivative Immunotherapy in the Treatment of Viral Warts},
journal = {Indian Journal of Drugs in Dermatology},
year = {2016},
doi = {10.4103/2455-3972.184103}
}
EUVIMED